請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/10674
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 董馨蓮 | |
dc.contributor.author | Wen-Hui Chuang | en |
dc.contributor.author | 莊文蕙 | zh_TW |
dc.date.accessioned | 2021-05-20T21:48:58Z | - |
dc.date.available | 2013-09-09 | |
dc.date.available | 2021-05-20T21:48:58Z | - |
dc.date.copyright | 2010-09-09 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-08-03 | |
dc.identifier.citation | Akagi, T., Motegi, M., Tamura, A., Suzuki, R., Hosokawa, Y., Suzuki, H., Ota, H., Nakamura, S., Morishima, Y., Taniwaki, M., and Seto, M. (1999) A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 18, 5785-5794.
Baud, V., and Karin, M. (2009) Is NF-κB a good target for cancer therapy? Hopes and Pitfalls. Nat. Rev. Drug Discov. 8, 33-40. Bertin, J., Guo, Y., Wang, L., Srinivasula, S.M., Jacobson, M.D., Poyet, J.L., Merriam, S., Du, M.Q., Dyer, M.J., Robison, K.E., DiStefano, P.S., and Alnemri, E.S. (2000) CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-κ B. J. Biol. Chem. 275, 41082-41086. Bertin, J., Wang, L., Guo, Y., Jacobson, M. D., Poyet, J. L., Srinivasula, S. M., Merriam, S., DiStefano, P. S. and Alnemri, E. S. (2001) CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-κB. J. Biol. Chem. 276, 11877-11882. Bertoni, A., S. Tadokoro, K. Eto, N. Pampori, L.V. Parise, G.C. White, and S.J. Shattil. (2002) Relationships between Rap1b, affinity modulation of integrin α IIbβ3, and the actin cytoskeleton. J. Biol. Chem. 277, 25715–25721. Blanchet, F., Cardona, A., Letimier, F.A. Hershfield, M.S. and Acuto, O. (2005) CD28 costimulatory signal induces protein arginine methylation in T cells. J. Exp. Med. 202, 371-373. Blonska, M., Pappu, B., Matsumoto, R., Li, H., Su, B., Wang, D., and Lin, X. (2007) The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway. Immunity 26, 55-66. Burbach, B.J., Srivastava, R., Medeiros, R.B., O’Gorman, W.E., Peterson, E.J., and Shimizu, Y. (2008) Distinct regulation of intergrin-depedent T cell conjugate formation and NF-B activation by the adapter protein ADAP. J. Immunol. 181, 4840-4851. B. Keil. (1992) Specificity of Proteolysis. Springer-Verlag Berlin, Germany Che, T., You, Y., Wang, D., Tanner, M.J., Dixit, V.M., and Lin, X. (2004) MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation. J. Biol. Chem. 279, 15870-15876. Coornaert, B., Baens, M., Heyninck, K., Bekaert, T., Haegman, M., Staal, J., Sun, L., Chen, Z.J., Marynen, P., and Beyaert, R. (2008) T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20. Nat. Immunol. 9, 263-271. Denault, J. and Salvesen, G.S. (2001) Caspase. Curr. Protoc. Protein Sci. Chapter 21, unit 21.8 Dong, W., Liu, Y., Peng, J., Chen, L., Zou, T., Xiao, H., Liu, Z., Li, W., Bu, Y., and Qi, Y. (2006) The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-κB from Toll-like receptor 4. J. Biol. Chem. 281, 26029-26040. Felicia, D. L., Nidhi, A J., Jeremy, S. R., Lara, M. K., Anuj, K. K., and Brian, C. S. (2008) Multiple protein domains mediate interaction between Bcl10 and Malt1. J. Biol. Chem. 283, 32419-32431. Ferch, U., Kloo, B., Gewies, A., Pfander, V., Duwel, M., Peschel, C., Krappmann, D., and Ruland, J. (2009) Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 206, 2313-2320. Fuentes-Prior, P., and Salvesen, G..S. (2004) The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 384, 201-232. Gaide, O., Martinon, F., Micheau, O., Bonnet, D., Thome, M., and Tschopp, J. (2001) CARMA1, a CARD-containing binding partner of BCL10, induces BCL10 phosphorylation and NF-κB activation. FEBS Lett. 496, 121-127. Grabiner, B.C., Blonska, M., Lin, P.C., You, Y., Wang, D., and Sun, J. (2007) CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes Dev. 21, 984–996. Gross, O., Gewies, A., Finger, K., Schafer, M., Sparwasser, T., Peschel, C., Forster, I., and Ruland, J. (2006) CARD9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442, 651-656. Gross, O., Grupp, C., Steinberg, C., Zimmermann, S., Strasser, D., Hannesschlager, N., Reindl, W., Jonsson, H., Huo, H.R., Littman, D.R., Peschel, C., Yokoyama, W.M., Krug, A., and Ruland, J. (2008) Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-κB and MAPK activation to selectively control cytokine production. Blood 112, 2421-2428. Hailfinger, S., Reveaud, F., and Thome, M. (2009) Adaptor and enzyme functions of protease in T-cell activation. Immunol. Rev. 232, 334-347. Hailfinger, S., Lenz, G., Ngo, V., Posvitz-Fejfar, A., Reveard, F., Guzzardi, M., Penas, E.M., Dierlamm, J., Chan, W.C., Staudt, L.M., and Thome, M. (2009) Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc. Natl. Acad. Sci. USA 106, 19946-19951. Hara, H., Ishihara, C., Takeuchi, A., Imanishi, T., Xue, L., Morris, S.W., Inui, M., Takai, T., Shibuya, A., Saijo, S., Iwakura, Y., Ohno, N., Haruhiko, K., Hiroki, Y., Penninger, J.M., and Saito, T. (2007) The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 8 619-629. Hara, H. and Saito, T. (2009) CARD9 versus CARMA1 in innate and adaptive immunity. Trends Immunol. 30, 234-242. Hu, S., Du, M.Q., Park, S.M., Alcivar, A., Qu, L., Gupta, S. Tang, J., Baens, M., Ye, H., Lee, T.H., Marynen, P., Riley, J.L., and Yang, X. (2006) cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. J. Clin. Invest. 116, 174–181 Isakov, N. (1998) Role of immunoreceptor tyrosine-based activation motif in signal transduction from antigen and Fc receptors. Adv. Immunol. 69, 183-247. Ishiguro, K., Ando, T., Goto, H., and Xavier, R. (2007) BCL10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II. Mol. Immunol. 44, 2095-2100. Kane, L.P., Lin, J., and Weiss, A. (2000) Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12, 242-249. Kawadler H., Gantz MA., Riley JL., and Xiaolu Y. (2008) The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Cell 31, 415-421. Klemm, S., Zimmermann, S., Peschel, C., Mak, T.W., and Ruland, J. (2007) BCL10 and MALT1 control lysophosphatidic acid-induced NF-κB activation and cytokine production. Proc. Natl. Acad. Sci. USA 104, 134-138. Langel, F.D., Jain, N.A., Rossman, J.S., Kingeter, L.M., Kashyap, A.K. and Schaefer, B.C. (2008) Multiple protein domains mediate interaction between BCL10 and MALT1. J. Biol. Chem. 283, 32419-32431. Lobry, C., Lopez, T., Israel, A., and Weil, R. (2007) Negative feedback loop in T cell activation through IκB kinase-induced phosphorylation and degradation of BCL10. Proc. Natl. Acad. Sci. USA 104, 908-913. Liu, Y., Dong, W., Chen, L., Xiang, R., Xiao, H., De, G., Wang, Z., and Qi, Y. (2004) BCL10 mediates lipopolysaccharide/toll-like receptor-4 signaling through interaction with Pellino2. J. Biol. Chem. 279, 37436-37444. Malarkannan, S., Regunathan, J., Chu, H., Kutlesa, S., Chen, Y., Zeng, H., Wen, R., and Wang, D. (2007) BCL10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation. J. Immunol. 179, 3752-3762. Matsumoto, R., Wang, D., Blonska, M., Li, H., Kobayashi, M., Pappu, B., Chen, Y., Wang, D., and Lin, X. (2005) Phosphorylation of CARMA1 plays a critical role in T cell receptor-mediated NF-κB activation. Immunity 23, 575-585. Medeiros, R. B., Burbach, B. J., Mueller, K. L., Srivastava,R., Moon, J. J., Highfill, S. E., Peterson, J. and Shimizu, Y. (2007) Regulation of NF-κB activation in T cells via association of the adapter proteins ADAP and CARMA1. Science 316, 754–758. Misra, R.S., Russell, J.Q., Koenig, A., Hindhaw-Makepeace, J.A., Wen, R., Wang, D., Huo, H., Littman, D.R., Ferch, U., Ruland, J., Thome, M., and Budd, R.C. (2007) Caspase-8 and c-FLIPL associate in lipid rafts with NF-κB adaptors during T cell activation. J. Biol. Chem. 282, 19365-19374. Mowen, K.A., Schurter, B.T., Fathman, J.W., David, M and Glimcher, L.H. (2004) Arginine methylation NIP45 modulates cytokine gene expression in effector T lymphocytes. Cell 15, 559-571. Najbauer, J., Johnson, B., Young, A., and Aswad, D. (1993) Peptides with sequence similar to glycine, arginine-rich motifs in proteins interacting with RNA are efficiently recognized by methyltransferase(s) modifying arginine in numerous proteins. J. Biol. Chem. 269, 10501-10509. Noels, H., Loo, G., Hagens, S. Broeckx, V., Beyaert, R., Marynen, P., and Baens, M. (2007) A novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-κB activation by API2-MALT1 fusions. J. Biol. Chem. 282, 10180-10189. Oeckinghaus, A., Wegener, E., Welteke, V., Ferch, U., Arslan, S.C., Ruland, J., Scheidereit, C., and Krappmann, D. (2007) Malt1 ubiquitination triggers NF-κB signaling upon T-cell activation. EMBO J. 26, 4634-4645. Ong, S.E., Mittler, G. and Mann, M. (2004) Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. Nat. Methods 1, 119-126. Parry, R.V., and Ward, S.G. (2010) Protein arginine methylatin: a new handle on T lymphocytes? Trends Immunol. 31, 164-169. Rawlings, D.J, Sommer, K., and Moreno-Garcia, M.E. (2006) The CARMA1 signalosome links the signaling machinery of adaptive and innate immunity in lymphocytes. Nat. Rev. Immunol. 6, 799-812. Rebeaud, F., Hailfinger, S., Posevitz-Fejfar, A., Tapernoux, M., Moser, R., Rueda, D., Gaide, O., Guzzardi, M., Iancu, E.M., Rufer, N., Fasel, N., and Thome, M. (2008) The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat. Immunol. 9, 272-281. Rueda, D., Gaide, O., Ho, L., Gewkowicz, E., Niedergang, F., Hailfinger, S., Reveaud, F., Guzzardi, M., Conne, B., Thelen, M., Delon, J., Ferch, U., Mak, T.W.., Ruland, J., Schwaller, J., and Thome, M. (2007) Bcl10 controls TCR- and FcgammaR-induced actin polymerization. J. Immunol. 178, 4373-4384. Ruefli-Brasse, A.A., French, D.M., and Dixit, V.M. (2003) Regulation of NF-κB-dependent lymphocyte activation and development by paracaspase. Science 302, 1581-1584. Ruland, J., Duncan, G.S., Elia, A., del Barco Barrantes, I., Nguyen, L., Plyte, S., Millar, D.G., Bouchard, D., Wakeham, A., Ohashi, P.S., and Mak, T.W. (2001) BCL10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104, 33-42. Ruland, J., Duncan, G..S., Wakeham, A., and Mak, T.W. (2003) Differential requirement for MALT1 in T and B cell antigen receptor signaling. Immunity 19, 749-758. Samelson, L.E. (2002) Signal transduction mediated by the T cell antigen receptor: the role of adaptor proteins. Annu. Rev. Immunol. 20, 371-394. Scharschmidt, E., Wegener, E., Heissmeyer, V., Rao, A., and Krappmann D. (2004) Degradation of BCL10 induced by T-cell activation negatively regulates NF-κ B signaling. Mol. Cell Biol. 24, 3860-3873. Schaefer, B. C., Kappler, J.W., Kupfer, A., and Marrack, P. (2004) Complex and dynamic redistributionof NF-kappaB signaling intermediates in response to T cell receptor stimulation. Proc. Natl. Acad. Sci. USA 101, 1004-1009. Sixt, M., Bauer, M., Lammermann, T., and Fassler, R. (2006) β1-integrins: zip codes and signaling relay for blood cells. Curr. Opin. Cell Biol. 18, 482-490. Snipas, S.J., Wildfang, E., Nazif, T., Christensen, L., Boatright, K.M., Bogyo, M., Stennicke, H.R. and Salvesen, G..S. (2004) Characteristics of the caspase-like catalytic domain of human paracaspase. Biol. Chem. 385, 1093-1098. Sommer, K., Guo, B., Pomerantz, J.L., Bandaranayake, A.D., Moreno-García, M.E., Ovechkina, Y.L., and Rawlings, D.J. (2005) Phosphorylation of CARMA1 linker controls NF-κB activation. Immunity 23, 561-574. Su, H., Bidere, N., Zheng, L., Cubre, A., Sakai, K., Dale, J., Salmena, L., Hakem, R., Straus, S., and Lenardo, M. (2005) Requirement for caspase-8 in NF-kB activation by antigen receptor. Science 307, 1465–1468. Sun, L., Deng, L., Ea, C.K., Xia, Z.P., and Chen, Z.J. (2004) The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Cell 14, 289-301. Sun, J., Lin, X. (2008) Aarrestin 2 is required for lysophosphatidic acid-induced NF-B activation. Proc. Natl. Acad. Sci. USA 105, 17085-17090. Sun, W., and Yang, J. (2010) Molecular basis of lysophosphatidic acid-induced NF-κB activation. Cell Signaling [Epub ahead of print] Thome, M. (2008) Multifunctional roles for MALT1 in T cell activation. Nat. Rev. Immunol. 8, 495-500. Uren, A.G., O'Rourke, K., Aravind, L.A., Pisabarro, M.T., Seshagiri, S., Koonin, E.V., and Dixit, V.M. (2000) Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Cell 6, 961-967. Wang, L., Guo, Y., Huang, W.J., Ke, X., Poyet, J.L., Manji, G.A., Merriam, S., Glucksmann, M.A., DiStefano, P.S., Alnemri, E.S., and Bertin, J. (2001) CARD10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-κB. J. Biol. Chem. 276, 21405-21409. Wang, D., You, Y., Lin, P.C., Xue, L. Morris, S.W., Zeng, H., Wen, R., and Lin, X. (2007) Bcl10 plays a critical role in NF-κB activation induced by G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 104, 145-150. Wang, P., Wu, X., Chen, W., Liu, J., and Wang, X. (2007) The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms. Gynecol. Oncol. 104, 714-720. Weber, S., Maass, F., Schuemann, M., Krause, E., Suske, G. and Bauer, U.M. (2009) PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling. Gene Dev. 23, 118-132. Wegener, E., and Krappmann, D. (2007) CARD-BCL10-MALT1 signalosomes: missing link to NF-κB. Sci. STKE. 384, pe21 Wegener, E., Oechinghaus, A., Papadopoulou, N., Lavitas, L., Schmidt-Supprian, M., Ferch, U., Mak, T.W., Ruland, J., Heissmeyer, V., and Krappmann, D. (2006) Essential role for IkB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation. Cell 23, 13-23. Welteke, V., Eitelhuber, A., Düwel, M., Schweitzer, K., Naumann, M. and Krappmann, D. (2009) COP9 signalosome controls the Carma1–Bcl10–Malt1 complex upon T-cell stimulation. EMBO report 10, 642-648. Wills, T. G., Jadayer,D.M., Du,M.Q., Peng,H., Perry, A. R., Abdul-Rauf, M., Price, H., Karran, L., Majekodunmi, O., Wlodarsda, I., Pan, L., Crook,T., Hamoudi, R., Isaacson, P.G., and Dyer, M. J. (1999) Bc10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96, 35-45. Wu, C.J., and Ashwell, J.D. (2008) NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-κB activation. Proc. Natl. Acad. Sci. USA 105, 3023-3028. Zhang, Q., Siebert, R., Yan, M., Hinzmann, B., Cui, X., Xue, L., Rakestraw, K.M., Naeve, C.W., Beckmann, G., Weisenburger, D.D., Sanger, W.G., Nowotny, H., Vesely, M., Callet-Bauchu, E., Salles, G., Dixit, V.M., Rosenthal, A., Schlegelberger, B., and Morris, S.W. (1999) Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat. Genet. 22, 63-68. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/10674 | - |
dc.description.abstract | BCL10與MALT1可互相結合且在許多的細胞之中皆有表現。在細胞受到刺激後可與不同的CARD-containing蛋白質形成CBM複合體,對於NF-κB引起的訊息傳導路徑中扮演不可或缺的角色。在本實驗室與他人之前的研究得知,利用TPA (12-O-tetradecanoly-phorbol-13-acetate) 及Ionomycin刺激Jurkat T cell後,MALT1可切割在BCL10的C端。本實驗室針對可疑的切點在BCL10 GFP做一連串的刪除實驗,推論切點位於BCL10第225個胺基酸白胺酸(Leucine),不同於2008年被報導的切點第228個胺基酸精胺酸(Arginine)。因此,本篇論文將以數種方法釐清被切割的BCL10其確切的切割點,並研究BCL10被切割後C端的小片段胜肽在細胞內所在的位置,進一步去探討可能所扮演的角色。
首先,本篇論文以DSS cross-linker鍵結BCL10抗體與protein G,用以純化產物,蛋白質來源為以TPA及Ionomycin刺激Jurkat T細胞的全長或內生性被切割的BCL10,結果顯示每次以2×108 細胞數進行純化,80 μg的BCL10抗體僅能結合5-10 ng BCL10。第二,構築質體FlagBCL10 GFP並與MALT1在293T細胞共同表現,以FLAG親和凝膠純化被切割的產物,結果顯示每10 μl凝膠可以結合約50 ng的切割後產物。純化的蛋白以LC-MS/MS進行分析,並先利用Asp-N內切酶處理樣品。Asp-N可切在aspartate的N端,針對BCL10被MALT1切割後可能出現的蛋白質處理Asp-N,全長BCL10、BCL10 1-225、BCL10 1-228分別可得到3196.5 daltons、2225.9 daltons及2625.2 daltons,皆可以LC-MS/MS準確分析結果。不幸的是,由於Asp-N切點前具有proline,目前仍無法分析這些片段。毛細管電泳亦被應用於分析切割後的C端胜肽RSRTVSRQ與TVSRQ,結果顯示雖然可以有效區分此2段C端胜肽,但靈敏度僅有5 ppm。 針對可疑的切點,以degenerate引子對Leu225及Arg228進行單點突變得到以下融合蛋白BCL10 L225A、BCL10 L225G、BCL10 L225Q、BCL10 L225K、BCL10 L225R、BCL10 L225E及BCL10 R228G,並在293T細胞中分別與MALT1共同表現,以釐清BCL10 Leu225與Arg228對於切割能力有無所扮演的角色。結果顯示除了BCL10 L225R與BCL10 L225K以外,所有的mutants皆無被切割現象,指出BCL10 Leu225與Arg228對於切割是重要的。有趣的是,將融合蛋白BCL10 L225R,R228G與MALT1共同表現於細胞中,仍具有被切割的能力。另外在BCL10 L225R上針對Phe222及Leu223進行點突變以分析BCL10對MALT1切割能力的影響,結果顯示僅有BCL10 F222A,L223T,L225R (FL-4) 仍舊保有被MALT1切割的能力,BCL10 F222H,L223E,L225R (FL-1)、BCL10 F222S,L223E,L225R (FL-2)、BCL10 F222E,L223A,L225R (FL-3)則無法被切割,對於這些融合蛋白影響MALT1的切割能力有無的機制將在內文中討論。 為了研究BCL10被切割後C端胜肽在細胞內所在的位置,我們欲直接將胜肽送入細胞以便觀察,但無法成功。因此在GFP的C端接上胜肽RSRTVSRQ得到融合蛋白GFP-RSRTVSRQ,結果顯示GFP-RSRTVSRQ如同GFP的表現,均勻分布在細胞中。而共同表現BCL10與GFP-RSRTVSRQ並不影響由BCL10所引起的NF-κB的活性。 | zh_TW |
dc.description.abstract | BCL10 and MALT1 interacted with each other and were present in many cells. Upon stimulation, they associated with various CARD-containing proteins to form CBM complexes which then mediated the activation of NF-κB signaling pathway. Previously, we and others demonstrated that BCL10 was cleaved in the C-terminus by MALT1 in Jurkat T cells treated with TPA and ionomycin. In 2008, amino acid residue Arg228 of BCL10 was reported to be the cleavage site. Different from what was reported, our serial deletion mutants of BCL10 suggested a probable cleavage site at Leu225. In the present study, several proteomic methods will be utilized to elucidate the discrepancy. The location and the function of the cleaved C-terminus peptides will also be investigated.
Firstly, anti-BCL10 antibodies were cross-linked to protein G sepharose chemically to generate an affinity column to purify either full length BCL10 or cleaved BCL10 from Jurkat T cells treated with TPA/Ionomycin or not. An average of 5-10 ng BCL10 could be generated from 2×108 cells using an affinity column made from 80μg antibody. Secondly, fusion construct FlagBCL10 GFP was generated. Co-transfection of FlagBCL10 GFP and MALT1 in 293T cells would generate truncated FlagBCL10 which could then be isolated by commercially available FLAG affinity gel. An average of 50 ng purified products could be generated from 10 μl packed gel. LC-MS/MS was utilized to identify the cleavage site. Protease, Asp-N, cleaved at the N-terminus of the amino acid residue aspartate. Treatment of full length BCL10 or BCL10 cleaved at Leu225 or at Arg228 with Asp-N would generate polypeptides with M.W. of 3196.5 daltons, 2225.9 daltons and 2625.2 daltons, respectively. These fragments should be easily distinguished by LC-MS/MS. Unfortunately, LC-MS/MS failed to detect these fragments so far. It might be due to the proline residue right before the Asp-N cleavage site. Capillary Zone Electrophoresis (CZE) was utilized to analyze the C-terminus peptides RSRTVSRQ and TVSRQ. The two peptides could be efficiently separated by CZE. The detection sensitivity was estimated to be 5 ppm. Site directed mutagenesis was employed to investigate the role of amino acid residues Leu225 and Arg228 of BCL10 played as a substrate of MALT1. Degenerate primers were utilized to generate the following mutants:BCL10 L225A, BCL10 L225G, BCL10 L225Q, BCL10 L225K, BCL10 L225R, BCL10 L225E, and BCL10 R228G. All mutant constructs were transfected into 293T cells along with the MALT1 expression vector and tested for their ability of being a proteolytic substrate. BCL10 L225K and BCL10 L225R could be processed by MALT1 as wild type BCL10. MALT1 failed to cleave the other mutants (BCL10 L225A, BCL10 L225G, BCL10 L225Q, BCL10 L225E, BCL10 R228G). These data suggested that both Leu225 and Arg228 were critical for cleavage. Interestingly, double mutants BCL10 L225R,R228G retained its ability to be cleaved by MALT1. Mutation at the amino acid residues Phe222 and Leu223 of BCL10 L225R affected its ability of being a substrate of MALT1. While BCL10 F222A,L223T,L225R (FL4) retained its ability as wild type BCL10, mutants BCL10 F222H,L223E,L225R (FL-1), BCL10F222S,L223E,L225R (FL-2) and BCL10F222E,L223A,L225R (FL-3) were not able to be processed. The mechanisms by which these mutations affected MALT-1-mediated cleavage on BCL10 will be discussed in the text. We failed to introduce the cleaved C-terminus polypeptides RSRTVSRQ into 293T cells. Therefore, the eight amino acid residues RSRTVSRQ at the C-terminus of BCL10 were fused at the C-terminus of GFP to investigate its effects. GFP-RSRTVSRQ showed a diffuse-distribution pattern as GFP. Expression of GFP-RSRTVSRQ did not have effect on BCL10-induced NF-κB activation. | en |
dc.description.provenance | Made available in DSpace on 2021-05-20T21:48:58Z (GMT). No. of bitstreams: 1 ntu-99-R97445128-1.pdf: 3323016 bytes, checksum: 4a46e09df206fa743d805d6d231332b6 (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii 英文摘要 v 目錄 viii 第壹章 序論 1 一、CBM complex在NF-κB訊息傳遞路徑扮演的角色 1 二、BCL10 3 三、MALT1 6 四、MALT1誘導切割BCL10 7 第貳章 研究目的 9 第参章 方法與材料 10 一、抗體來源 10 二、實驗使用之質體及質體構築 10 三、製備勝任細胞 (Preparation of competent cells) 11 四、細菌轉型 (Transformation) 11 五、小量質體製備 (mini-plasmid preparation) 11 六、大量質體製備 (maxi-plasmid preparation) 11 七、重組蛋白質的表現 (expression of recombinant proteins) 12 八、細胞培養 (Cell culture) 13 九、細胞轉染 (Transfection) 13 十 、TPA/Ionomycin treatment 14 十一、 Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) 14 十二、西方墨點分析 (Western blot analysis) 14 十三、蛋白質染色法 (Protein Staining) 15 十四、免疫沉澱 (Immunoprecipitation) 與去磷酸酵素作用 15 十五、蛋白質純化 (Protein purification) 16 十六、胜肽純化 (Peptide purification) 17 十七、螢光觀察與Hoechst染色 18 十八、冷光酵素測定 (Luciferase assay) 18 十九、毛細管帶狀電泳分析 (Capillary zone electrophoresis analysis) 18 二十、質譜樣品的製備 (Sample preparation for MS spectrometry) 與液態層析偶合串聯式質譜儀分析 (LC-MS/MS analysis) 19 第肆章 結果 21 一、找尋BCL10受MALT1誘導切割位置 21 二、探討BCL10受到切割後C端胜肽扮演的角色 24 第伍章 討論 26 第陸章 參考文獻 33 第柒章 結果圖表 40 第捌章 附錄圖表 54 | |
dc.language.iso | zh-TW | |
dc.title | MALT1對BCL10切割的切點位置探討 | zh_TW |
dc.title | Investigation on the cleavage site on BCL10 by MALT1 | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 周綠蘋,陳美如 | |
dc.subject.keyword | BCL10,MALT1,切割,白胺酸,精胺酸,胜肽, | zh_TW |
dc.subject.keyword | BCL10,MALT1,cleavage,Leucine,Arginine,peptides, | en |
dc.relation.page | 65 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2010-08-03 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 微生物學研究所 | zh_TW |
顯示於系所單位: | 微生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf | 3.25 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。